- Design of precise third-line therapy for gastric cancer: target or chemotherpy?
-
Cho JY
- KMID: 1776450
- Korean J Intern Med.
- 2013 May;28(3):297-299.
- doi: 10.3904/kjim.2013.28.3.297
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages
-
Cheung DY
- KMID: 2412059
- Gut Liver.
- 2016 Sep;10(5):659-660.
- doi: 10.5009/gnl16359
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Synchronous Early Gastric Cancer and Diffuse Large B Cell Lymphoma Treated with Endoscopic Submucosal Dissection and Chemotherapy
-
Park JH, Jang JY, Cho YD, Dong SH, Kim HJ, Kim BH, Chang YW
- KMID: 1792838
- Korean J Gastroenterol.
- 2012 May;59(5):377-381.
- doi: 10.4166/kjg.2012.59.5.377
Among malignant tumors of the stomach, adenocarcinoma takes up about 95% and the remaining are mostly lymphomas, being less than 5%. The majority of lymphomas are B cell lymphomas, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kim JH, Lee YC
- KMID: 782915
- Korean J Gastroenterol.
- 2007 Sep;50(3):207-209.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular targeted therapy for advanced gastric cancer
-
Kim JG
- KMID: 1501767
- Korean J Intern Med.
- 2013 Mar;28(2):149-155.
- doi: 10.3904/kjim.2013.28.2.149
Although medical treatment has been shown to improve quality of life and prolong survival, no significant progress has been made in the treatment of advanced gastric cancer (AGC) within the... -
- CITED
-
- Close
- SHARE
-
- Close
- Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells
-
Hong WS, Kim CM, Lee CT, Lee JO, Kang TW
- KMID: 1421919
- J Korean Med Sci.
- 1992 Sep;7(3):236-240.
- doi: 10.3346/jkms.1992.7.3.236
Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells.... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Comparison of Chemotherapy and Surgery for Early Stage Diffuse Large B-cell Gastric Lymphoma
-
Kim SJ, Cheong JW, Hahn JS
- KMID: 1786207
- Yonsei Med J.
- 2007 Dec;48(6):942-948.
- doi: 10.3349/ymj.2007.48.6.942
PURPOSE: The use of surgery versus stomach-preserving treatment for primary gastric lymphoma has caused controversy among doctors. This retrospective, single center study aims to evaluate the efficacy and benefit... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of a Home-based Exercise Program for Patients with Stomach Cancer Receiving Oral Chemotherapy after Surgery
-
Choi JY, Kang HS
- KMID: 1245162
- J Korean Acad Nurs.
- 2012 Feb;42(1):95-104.
- doi: 10.4040/jkan.2012.42.1.95
PURPOSE: The purpose of this study was to identify the effects of a home based exercise program for patients with stomach cancer who were undergoing oral chemotherapy. METHODS: The home-based exercise... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of FOLFIRI as Second-line Chemotherapy in Advanced Gastric Cancer
-
Park SC, Chun HJ
- KMID: 2373304
- Korean J Gastroenterol.
- 2015 Jul;66(1):1-4.
- doi: 10.4166/kjg.2015.66.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Paclitaxel and Cisplatin Combination Chemotherapy for the Treatment of Metastatic or Recurrent Gastric Cancer: a Multicenter Phase II Study
-
Shin SJ, Chun SH, Kim KO, Kim MK, Lee KH, Hyun MS, Bae SH, Ryoo HM, Do YR, Kwon KY, Song HS
- KMID: 1718035
- Korean J Intern Med.
- 2005 Jun;20(2):135-140.
- doi: 10.3904/kjim.2005.20.2.135
BACKGROUND: Although many treatments for advanced gastric cancer have been developed, only poor treatment results have generally been obtained. We performed a prospective study on the combination chemotherapy of paclitaxel... -
- CITED
-
- Close
- SHARE
-
- Close
- Perspectives of the Stomach Cancer Treatment: The Introduction of Molecular Targeted Therapy and the Hope for Cure
-
Cheung DY, Kim JK
- KMID: 1501634
- Korean J Gastroenterol.
- 2013 Mar;61(3):117-127.
- doi: 10.4166/kjg.2013.61.3.117
The overall survival of patients with gastric cancer has increased markedly in Korea, even higher than those of developed nations in Western world. It is due to the virtue of... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer
-
Min YJ, Bang SJ, Shin JW, Kim DH, Park JH, Kim GY, Ko BK, Choi DH, Cho HR
- KMID: 1786814
- J Korean Med Sci.
- 2004 Jun;19(3):369-373.
- doi: 10.3346/jkms.2004.19.3.369
Heptaplatin is a recently developed platinum derivative. This agent has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study
-
Baek JH, Kim JG, Sohn SK, Kim DH, Lee KB, Song HS, Kwon KY, Do YR, Ryoo HM, Bae SH, Park KU, Kim MK, Lee KH, Hyun MS, Chung HY, Yu W
- KMID: 2157746
- J Korean Med Sci.
- 2005 Dec;20(6):966-970.
- doi: 10.3346/jkms.2005.20.6.966
The current phase II study was conducted to evaluate the response rate and safety of a combination regimen of biweekly irinotecan plus cisplatin in pretreated patients with advanced gastric cancer.... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
-
Hwang J, Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ
- KMID: 1785814
- J Korean Med Sci.
- 2008 Aug;23(4):586-591.
- doi: 10.3346/jkms.2008.23.4.586
This phase II study evaluated the efficacy and safety of combination chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were eligible... -
- CITED
-
- Close
- SHARE
-
- Close
- Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
-
Gong EJ, Ahn JY, Jung HY, Park H, Ko YB, Na HK, Jung KW, Kim DH, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH
- KMID: 2412066
- Gut Liver.
- 2016 Sep;10(5):706-713.
- doi: 10.5009/gnl15510
BACKGROUND/AIMS: We investigated the effectiveness of Helicobacter pylori eradication therapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma regardless of the H. pylori infection status or disease stage. METHODS: From November 1995... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
-
Kang SH, Kim JI, Moon HS, Kim SH, Sung JK, Lee BS, Jeong HY
- KMID: 1775923
- Korean J Gastroenterol.
- 2010 Jan;55(1):26-32.
- doi: 10.4166/kjg.2010.55.1.26
BACKGROUND/AIMS: We performed retrospective study in order to compare oxaliplatin, leucovorin, and fluorouracil (FOLFOX) versus irinotecan, leucovorin, and fluorouracil (FOLFIRI) in recurred or metastatic gastric adenocarcinoma. METHODS: We investigated 56 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy in the Treatment of Gastric Cancer
-
Ahn MJ
- KMID: 772609
- Korean J Gastroenterol.
- 2004 Feb;43(2):75-81.
Despite the reduced incidence and mortality, gastric cancer remains the second leading cause of cancer death in Korea. Metastatic gastric cancer is regarded as an incurable condition, and chemotherapy is... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Toxicities and Efficacies of the Combination Chemotherapy Regimens in Advanced Gastric Cancer Patients Who Achieved Complete Response after Chemotherapy
-
Kim YJ, Goh PG, Kim ES, Lee SY, Moon HS, Lee ES, Sung JK, Kim SH, Lee BS, Jeong HY
- KMID: 1043329
- Korean J Gastroenterol.
- 2011 Dec;58(6):311-317.
- doi: 10.4166/kjg.2011.58.6.311
BACKGROUND/AIMS: We retrospectively analyzed comparative toxicities and efficacies of chemotherapy regimens in advanced gastric cancer (AGC) patients who achieved complete response (CR) after chemotherapy. METHODS: We reviewed the medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
